Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to ...

How does a healthcare system assess the value of innovation, whether in the form of new diagnostics, devices, medicines or other technology?

Johnson & Johnson (J&J) has announced that the National Institute for Health and Care Excellence (NICE) has published Final ...

Eli Lilly has entered into an agreement to acquire Dice Therapeutics for approximately $2.4bn, marking a significant boost to its immunology pipeline. The deal grants Lilly access to the biopharma’s ...

When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, ...

At eight years of follow-up, results showed that Tagrisso continued to show an OS benefit, reducing the risk of death ...

Inizio has appointed Oisín Ó Gógáin as Chief People Officer. Based at Inizio’s Dublin headquarters, Ó Gógáin joins from Aon, ...

Imfinzi is approved in the US, EU, Japan, China and many other countries around the world as the standard-of-care treatment ...

Roche’s Enspryng (satralizumab), a treatment for a rare autoimmune disease, has been given FDA Priority Review to a ...

Gilead Sciences has opened its 182,000-square-foot Research Center at its Foster City, California headquarters, expanding ...

Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine has been approved by the US FDA, with the companies announcing the ...

Stewart previously held roles at Saatchi & Saatchi Health London, part of the Publicis Health network, and Avalere, while ...